BioLife Solutions Q1 2025 Filing Released
Ticker: BLFS · Form: 10-Q · Filed: May 8, 2025 · CIK: 834365
| Field | Detail |
|---|---|
| Company | Biolife Solutions Inc (BLFS) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
BioLife Solutions filed its Q1 2025 10-Q, check financials for performance.
AI Summary
BioLife Solutions Inc. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing indicates financial data and operational segments, including product and service revenues, for the first quarter of 2025 and 2024. Specific financial figures for revenue, net income, or cash flow are not detailed in this header information.
Why It Matters
This filing provides an update on BioLife Solutions' financial performance and operational segments for the first quarter of 2025, which is crucial for investors to assess the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the absence of specific financial performance details in the provided header requires further investigation into the full document to assess risks.
Key Numbers
- 20250331 — Q1 2025 Period End (Reporting period for the 10-Q filing.)
- 20250508 — Filing Date (Date the 10-Q was officially filed with the SEC.)
Key Players & Entities
- BIOLIFE SOLUTIONS INC (company) — Filer
- 0000834365 (company) — Central Index Key
- DE (location) — State of Incorporation
- BOTHELL (location) — City
- WA (location) — State
- 20250331 (date) — Conformed Period of Report
- 20250508 (date) — Filed as of Date
FAQ
What were BioLife Solutions' total revenues for the first quarter of 2025?
The provided header information does not detail specific revenue figures for the first quarter of 2025. The full 10-Q document would contain this information.
Did BioLife Solutions report a net profit or loss in Q1 2025?
The header information for the 10-Q filing does not specify net income or loss for the first quarter of 2025. This detail would be found within the financial statements in the full report.
What is BioLife Solutions' primary industry classification?
BioLife Solutions Inc. is classified under ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS with the SIC code [3845].
When was the company incorporated?
The company was incorporated in Delaware (DE).
What are the main business segments reported by BioLife Solutions?
The filing indicates reporting segments for 'Product' and 'Service', with specific revenue data available for Q1 2025 and Q1 2024 for both.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding BIOLIFE SOLUTIONS INC (BLFS).